Prilide Antihypertensive Drugs - Global and China Top Players Market Share and Ranking 2023
This report studies and analyses global Prilide Antihypertensive Drugs status and future trends, helps the client to determine the Prilide Antihypertensive Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Prilide Antihypertensive Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Prilide Antihypertensive Drugs market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Prilide Antihypertensive Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Prilide Antihypertensive Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Prilide Antihypertensive Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Prilide Antihypertensive Drugs key producing regions, capacity, production, and year over year growth
(6) Prilide Antihypertensive Drugs industry chains, upstream, midstream and downstream
According to Latest Research, the global market for Prilide Antihypertensive Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Prilide Antihypertensive Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Prilide Antihypertensive Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Key Players Driving the Market:
Merck
Pfizer
Sanofi
Abbott
Novartis
Changzhou Pharmaceutical
Humanwell Pharmaceutical
Hengcheng Pharmaceutical
Hengwei Pharmaceutical
Zhongfu Pharmaceutical
Likang Pharmaceutical
Changjiang Pharmaceutical
Baiyunshan Pharmaceutical
Poly Pharm
Lukang Group
Baili Pharmaceutical
Huahai Pharmaceutical
By Product Type, the market is primarily segmented into:
Captopril
Enalapril
Lisinopril
Fosinopril
Others
By Applications, the market is segmented into:
Hospital
Clinic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe Prilide Antihypertensive Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Prilide Antihypertensive Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Prilide Antihypertensive Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Prilide Antihypertensive Drugs, percent & CAGR, 2018-2029
Chapter 5: Prilide Antihypertensive Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Prilide Antihypertensive Drugs Definition
1.2 Global Prilide Antihypertensive Drugs Market Size and Forecast
1.2.1 By Consumption Value, Global Prilide Antihypertensive Drugs Market Size，2018-2029
1.2.2 By Sales Quantity, Global Prilide Antihypertensive Drugs Market Size，2018-2029
1.2.3 Global Prilide Antihypertensive Drugs Average Selling Price (ASP)，2018-2029
1.3 China Prilide Antihypertensive Drugs Market Size and Forecast
1.3.1 By Consumption Value, China Prilide Antihypertensive Drugs Market Size，2018-2029
1.3.2 By Sales Quantity, China Prilide Antihypertensive Drugs Market Size，2018-2029
1.3.3 China Prilide Antihypertensive Drugs Average Selling Price (ASP)， 2018-2029
1.4 Share of China Prilide Antihypertensive Drugs Market with Respect to the Global Market
1.4.1 By Consumption Value, China Prilide Antihypertensive Drugs Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Prilide Antihypertensive Drugs Market Share in Global, 2018-2029
1.4.3 Prilide Antihypertensive Drugs Market Size: China VS Global, 2018-2029
1.5 Prilide Antihypertensive Drugs Market Dynamics
1.5.1 Prilide Antihypertensive Drugs Market Drivers
1.5.2 Prilide Antihypertensive Drugs Market Restraints
1.5.3 Prilide Antihypertensive Drugs Industry Trends
1.5.4 Prilide Antihypertensive Drugs Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Prilide Antihypertensive Drugs, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Prilide Antihypertensive Drugs, Global Market Share by Company, 2018-2023
2.3 Prilide Antihypertensive Drugs Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Prilide Antihypertensive Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Prilide Antihypertensive Drugs Concentration Ratio
2.6 Global Prilide Antihypertensive Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Prilide Antihypertensive Drugs Manufacturers Product Type
2.8 Head Office and Prilide Antihypertensive Drugs Production Site of Key Manufacturer
2.9 Prilide Antihypertensive Drugs Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Prilide Antihypertensive Drugs, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Prilide Antihypertensive Drugs, China Market Share by Company, 2018-2023
3.3 China Prilide Antihypertensive Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Prilide Antihypertensive Drugs Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Prilide Antihypertensive Drugs Capacity by Region
4.3 Global Prilide Antihypertensive Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Prilide Antihypertensive Drugs Production by Region, 2018-2029
4.5 Global Prilide Antihypertensive Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Prilide Antihypertensive Drugs Industry Chain
5.2 Prilide Antihypertensive Drugs Upstream Analysis
5.2.1 Prilide Antihypertensive Drugs Core Raw Materials
5.2.2 Main Manufacturers of Prilide Antihypertensive Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Prilide Antihypertensive Drugs Production Mode
5.6 Prilide Antihypertensive Drugs Procurement Model
5.7 Prilide Antihypertensive Drugs Industry Sales Model and Sales Channels
5.7.1 Prilide Antihypertensive Drugs Sales Model
5.7.2 Prilide Antihypertensive Drugs Typical Distributors
6 Sights by Type
6.1 Prilide Antihypertensive Drugs Classification
6.1.1 Captopril
6.1.2 Enalapril
6.1.3 Lisinopril
6.1.4 Fosinopril
6.1.5 Others
6.2 By Type, Global Prilide Antihypertensive Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Prilide Antihypertensive Drugs Consumption Value, 2018-2029
6.4 By Type, Global Prilide Antihypertensive Drugs Sales Quantity, 2018-2029
6.5 By Type, Global Prilide Antihypertensive Drugs Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Prilide Antihypertensive Drugs Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global Prilide Antihypertensive Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Prilide Antihypertensive Drugs Consumption Value, 2018-2029
7.4 By Application, Global Prilide Antihypertensive Drugs Sales Quantity, 2018-2029
7.5 By Application, Global Prilide Antihypertensive Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Prilide Antihypertensive Drugs Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Prilide Antihypertensive Drugs Consumption Value, 2018-2029
8.3 By Region, Global Prilide Antihypertensive Drugs Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Prilide Antihypertensive Drugs & Forecasts, 2018-2029
8.4.2 By Country, North America Prilide Antihypertensive Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Prilide Antihypertensive Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Prilide Antihypertensive Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Prilide Antihypertensive Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Prilide Antihypertensive Drugs Market Size Market Share
8.7 South America
8.7.1 South America Prilide Antihypertensive Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Prilide Antihypertensive Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Prilide Antihypertensive Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Prilide Antihypertensive Drugs Consumption Value, 2018-2029
9.3 By Country, Global Prilide Antihypertensive Drugs Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Prilide Antihypertensive Drugs Market Size, 2018-2029
9.4.2 By Type, U.S. Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Prilide Antihypertensive Drugs Market Size, 2018-2029
9.5.2 By Type, Europe Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Prilide Antihypertensive Drugs Market Size, 2018-2029
9.6.2 By Type, China Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Prilide Antihypertensive Drugs Market Size, 2018-2029
9.7.2 By Type, Japan Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Prilide Antihypertensive Drugs Market Size, 2018-2029
9.8.2 By Type, South Korea Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Prilide Antihypertensive Drugs Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Prilide Antihypertensive Drugs Market Size, 2018-2029
9.10.2 By Type, India Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Prilide Antihypertensive Drugs Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Merck
10.1.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.1.2 Merck Prilide Antihypertensive Drugs Models, Specifications, and Application
10.1.3 Merck Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Merck Company Profile and Main Business
10.1.5 Merck Recent Developments
10.2 Pfizer
10.2.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.2.2 Pfizer Prilide Antihypertensive Drugs Models, Specifications, and Application
10.2.3 Pfizer Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Pfizer Company Profile and Main Business
10.2.5 Pfizer Recent Developments
10.3 Sanofi
10.3.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.3.2 Sanofi Prilide Antihypertensive Drugs Models, Specifications, and Application
10.3.3 Sanofi Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Sanofi Company Profile and Main Business
10.3.5 Sanofi Recent Developments
10.4 Abbott
10.4.1 Abbott Company Information, Head Office, Market Area, and Industry Position
10.4.2 Abbott Prilide Antihypertensive Drugs Models, Specifications, and Application
10.4.3 Abbott Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Abbott Company Profile and Main Business
10.4.5 Abbott Recent Developments
10.5 Novartis
10.5.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.5.2 Novartis Prilide Antihypertensive Drugs Models, Specifications, and Application
10.5.3 Novartis Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Novartis Company Profile and Main Business
10.5.5 Novartis Recent Developments
10.6 Changzhou Pharmaceutical
10.6.1 Changzhou Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.6.2 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
10.6.3 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Changzhou Pharmaceutical Company Profile and Main Business
10.6.5 Changzhou Pharmaceutical Recent Developments
10.7 Humanwell Pharmaceutical
10.7.1 Humanwell Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.7.2 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
10.7.3 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Humanwell Pharmaceutical Company Profile and Main Business
10.7.5 Humanwell Pharmaceutical Recent Developments
10.8 Hengcheng Pharmaceutical
10.8.1 Hengcheng Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.8.2 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
10.8.3 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Hengcheng Pharmaceutical Company Profile and Main Business
10.8.5 Hengcheng Pharmaceutical Recent Developments
10.9 Hengwei Pharmaceutical
10.9.1 Hengwei Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.9.2 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
10.9.3 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Hengwei Pharmaceutical Company Profile and Main Business
10.9.5 Hengwei Pharmaceutical Recent Developments
10.10 Zhongfu Pharmaceutical
10.10.1 Zhongfu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.10.2 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
10.10.3 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Zhongfu Pharmaceutical Company Profile and Main Business
10.10.5 Zhongfu Pharmaceutical Recent Developments
10.11 Likang Pharmaceutical
10.11.1 Likang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.11.2 Likang Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
10.11.3 Likang Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Likang Pharmaceutical Company Profile and Main Business
10.11.5 Likang Pharmaceutical Recent Developments
10.12 Changjiang Pharmaceutical
10.12.1 Changjiang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.12.2 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
10.12.3 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Changjiang Pharmaceutical Company Profile and Main Business
10.12.5 Changjiang Pharmaceutical Recent Developments
10.13 Baiyunshan Pharmaceutical
10.13.1 Baiyunshan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.13.2 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
10.13.3 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Baiyunshan Pharmaceutical Company Profile and Main Business
10.13.5 Baiyunshan Pharmaceutical Recent Developments
10.14 Poly Pharm
10.14.1 Poly Pharm Company Information, Head Office, Market Area, and Industry Position
10.14.2 Poly Pharm Prilide Antihypertensive Drugs Models, Specifications, and Application
10.14.3 Poly Pharm Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Poly Pharm Company Profile and Main Business
10.14.5 Poly Pharm Recent Developments
10.15 Lukang Group
10.15.1 Lukang Group Company Information, Head Office, Market Area, and Industry Position
10.15.2 Lukang Group Prilide Antihypertensive Drugs Models, Specifications, and Application
10.15.3 Lukang Group Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Lukang Group Company Profile and Main Business
10.15.5 Lukang Group Recent Developments
10.16 Baili Pharmaceutical
10.16.1 Baili Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.16.2 Baili Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
10.16.3 Baili Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Baili Pharmaceutical Company Profile and Main Business
10.16.5 Baili Pharmaceutical Recent Developments
10.17 Huahai Pharmaceutical
10.17.1 Huahai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.17.2 Huahai Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
10.17.3 Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Huahai Pharmaceutical Company Profile and Main Business
10.17.5 Huahai Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Prilide Antihypertensive Drugs Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Prilide Antihypertensive Drugs Market Restraints
Table 3. Prilide Antihypertensive Drugs Market Trends
Table 4. Prilide Antihypertensive Drugs Industry Policy
Table 5. Global Prilide Antihypertensive Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Prilide Antihypertensive Drugs Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Prilide Antihypertensive Drugs Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Prilide Antihypertensive Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Prilide Antihypertensive Drugs Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Prilide Antihypertensive Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Prilide Antihypertensive Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Prilide Antihypertensive Drugs Manufacturers Product Type
Table 13. Head Office and Prilide Antihypertensive Drugs Production Site of Key Manufacturer
Table 14. Prilide Antihypertensive Drugs Capacity of Major Manufacturers and Future Plan
Table 15. China Prilide Antihypertensive Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Prilide Antihypertensive Drugs Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Prilide Antihypertensive Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Prilide Antihypertensive Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Prilide Antihypertensive Drugs Production by Region, 2018-2023, (K Units)
Table 20. Global Prilide Antihypertensive Drugs Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Prilide Antihypertensive Drugs Upstream (Raw Materials)
Table 22. Global Prilide Antihypertensive Drugs Typical Customers
Table 23. Prilide Antihypertensive Drugs Typical Distributors
Table 24. By Type, Global Prilide Antihypertensive Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Prilide Antihypertensive Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Prilide Antihypertensive Drugs Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Prilide Antihypertensive Drugs Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Prilide Antihypertensive Drugs Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Prilide Antihypertensive Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Prilide Antihypertensive Drugs Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Prilide Antihypertensive Drugs Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Prilide Antihypertensive Drugs Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Prilide Antihypertensive Drugs Sales Quantity Market Share, 2018-2029
Table 34. Merck Company Information, Head Office, Market Area, and Industry Position
Table 35. Merck Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 36. Merck Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Merck Company Profile and Main Business
Table 38. Merck Recent Developments
Table 39. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 40. Pfizer Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 41. Pfizer Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Pfizer Company Profile and Main Business
Table 43. Pfizer Recent Developments
Table 44. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 45. Sanofi Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 46. Sanofi Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Sanofi Company Profile and Main Business
Table 48. Sanofi Recent Developments
Table 49. Abbott Company Information, Head Office, Market Area, and Industry Position
Table 50. Abbott Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 51. Abbott Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Abbott Company Profile and Main Business
Table 53. Abbott Recent Developments
Table 54. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 55. Novartis Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 56. Novartis Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Novartis Company Profile and Main Business
Table 58. Novartis Recent Developments
Table 59. Changzhou Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 60. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 61. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Changzhou Pharmaceutical Company Profile and Main Business
Table 63. Changzhou Pharmaceutical Recent Developments
Table 64. Humanwell Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 65. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 66. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Humanwell Pharmaceutical Company Profile and Main Business
Table 68. Humanwell Pharmaceutical Recent Developments
Table 69. Hengcheng Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 70. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 71. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Hengcheng Pharmaceutical Company Profile and Main Business
Table 73. Hengcheng Pharmaceutical Recent Developments
Table 74. Hengwei Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 75. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 76. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Hengwei Pharmaceutical Company Profile and Main Business
Table 78. Hengwei Pharmaceutical Recent Developments
Table 79. Zhongfu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 80. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 81. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Zhongfu Pharmaceutical Company Profile and Main Business
Table 83. Zhongfu Pharmaceutical Recent Developments
Table 84. Likang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 85. Likang Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 86. Likang Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Likang Pharmaceutical Company Profile and Main Business
Table 88. Likang Pharmaceutical Recent Developments
Table 89. Changjiang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 90. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 91. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Changjiang Pharmaceutical Company Profile and Main Business
Table 93. Changjiang Pharmaceutical Recent Developments
Table 94. Baiyunshan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 95. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 96. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Baiyunshan Pharmaceutical Company Profile and Main Business
Table 98. Baiyunshan Pharmaceutical Recent Developments
Table 99. Poly Pharm Company Information, Head Office, Market Area, and Industry Position
Table 100. Poly Pharm Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 101. Poly Pharm Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Poly Pharm Company Profile and Main Business
Table 103. Poly Pharm Recent Developments
Table 104. Lukang Group Company Information, Head Office, Market Area, and Industry Position
Table 105. Lukang Group Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 106. Lukang Group Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Lukang Group Company Profile and Main Business
Table 108. Lukang Group Recent Developments
Table 109. Baili Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 110. Baili Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 111. Baili Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Baili Pharmaceutical Company Profile and Main Business
Table 113. Baili Pharmaceutical Recent Developments
Table 114. Huahai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 115. Huahai Pharmaceutical Prilide Antihypertensive Drugs Models, Specifications, and Application
Table 116. Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Huahai Pharmaceutical Company Profile and Main Business
Table 118. Huahai Pharmaceutical Recent Developments
List of Figures
Figure 1. Prilide Antihypertensive Drugs Picture
Figure 2. Global Prilide Antihypertensive Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Prilide Antihypertensive Drugs Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Prilide Antihypertensive Drugs Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Prilide Antihypertensive Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Prilide Antihypertensive Drugs Sales Quantity (K Units) & (2018-2029)
Figure 7. China Prilide Antihypertensive Drugs Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Prilide Antihypertensive Drugs Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Prilide Antihypertensive Drugs Market Share of Global, 2018-2029
Figure 10. Global Prilide Antihypertensive Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Prilide Antihypertensive Drugs Key Participants, Market Share, 2022
Figure 12. Global Prilide Antihypertensive Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Prilide Antihypertensive Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Prilide Antihypertensive Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 15. Prilide Antihypertensive Drugs Industry Chain
Figure 16. Prilide Antihypertensive Drugs Procurement Model
Figure 17. Prilide Antihypertensive Drugs Sales Model
Figure 18. Prilide Antihypertensive Drugs Sales Channels, Direct Sales, and Distribution
Figure 19. Captopril
Figure 20. Enalapril
Figure 21. Lisinopril
Figure 22. Fosinopril
Figure 23. Others
Figure 24. By Type, Global Prilide Antihypertensive Drugs Consumption Value, 2018-2029, US$ Million
Figure 25. By Type, Global Prilide Antihypertensive Drugs Consumption Value Market Share, 2018-2029
Figure 26. By Type, Global Prilide Antihypertensive Drugs Sales Quantity, 2018-2029, (K Units)
Figure 27. By Type, Global Prilide Antihypertensive Drugs Sales Quantity Market Share, 2018-2029
Figure 28. By Type, Global Prilide Antihypertensive Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 29. Hospital
Figure 30. Clinic
Figure 31. By Application, Global Prilide Antihypertensive Drugs Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Prilide Antihypertensive Drugs Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Prilide Antihypertensive Drugs Sales Quantity, 2018-2029, (K Units)
Figure 34. By Application, Global Prilide Antihypertensive Drugs Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global Prilide Antihypertensive Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 36. By Region, Global Prilide Antihypertensive Drugs Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global Prilide Antihypertensive Drugs Sales Quantity Market Share, 2018-2029
Figure 38. North America Prilide Antihypertensive Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America Prilide Antihypertensive Drugs Consumption Value Market Share, 2022
Figure 40. Europe Prilide Antihypertensive Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe Prilide Antihypertensive Drugs Consumption Value Market Share, 2022
Figure 42. Asia Pacific Prilide Antihypertensive Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific Prilide Antihypertensive Drugs Consumption Value Market Share, 2022
Figure 44. South America Prilide Antihypertensive Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America Prilide Antihypertensive Drugs Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Prilide Antihypertensive Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. Prilide Antihypertensive Drugs Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, U.S. Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Prilide Antihypertensive Drugs Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, Europe Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Prilide Antihypertensive Drugs Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, China Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Prilide Antihypertensive Drugs Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, Japan Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Prilide Antihypertensive Drugs Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, South Korea Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia Prilide Antihypertensive Drugs Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, Southeast Asia Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 65. India Prilide Antihypertensive Drugs Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, India Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa Prilide Antihypertensive Drugs Sales Quantity, 2018-2029, (K Units)
Figure 69. By Type, Middle East & Africa Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa Prilide Antihypertensive Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|